Emily Mills Johnson is a Irvine, California based psychiatrist who is specialized in Psychiatry. Her current practice location is 6 Venture, Ste 350, Irvine. Patients can reach her at 949-753-8800 or can fax her at 949-753-8899. Emily Mills Johnson is M.D. in Psychiatry and her NPI number (Unique professional ID assigned by NPPES) is 1063590438. Emily Mills Johnson specializes in the prevention, diagnosis, and treatment of mental disorders, emotional disorders, psychotic disorders, mood disorders, anxiety disorders, substance-related disorders, sexual and gender identity disorders and adjustment disorders. Biologic, psychological, and social components of illnesses are explored and understood in treatment of the whole person. Tools used may include diagnostic laboratory tests, prescribed medications, evaluation and treatment of psychological and interpersonal problems with individuals and families, and intervention for coping with stress, crises, and other problems.
Complete Profile:
Emily Mills Johnson speciality, credentials, practice address, contact phone number and fax are as below.
Patients can call on the below given phone number for appointment.
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1063590438
NPI Enumeration Date:
01 Nov, 2006
NPI Last Update On:
26 Apr, 2010
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
Emily Mills Johnson 6 Venture, Ste 350 Irvine, California
Zip:
92618-3340
Phone Number:
949-753-8800
Fax Number:
949-753-8899
Patients can reach Emily Mills Johnson at 6 Venture, Ste 350, Irvine, California or can call to book an appointment on 949-753-8800.
Comments/ Reviews:
Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 March, 2024.